UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical reviews in allergy & immunology, ISSN 1080-0549, 12/2013, Volume 45, Issue 3, pp. 331 - 379
Allergology | Animal models | Immunology | Respiratory syncytial virus | Medicine & Public Health | Cytokines | Internal Medicine | Infant mortality | Chemokines | Asthma | Bovine respiratory syncytial virus | Allergy | Life Sciences & Biomedicine | Science & Technology | Respiratory Syncytial Virus Vaccines - immunology | Respiratory Syncytial Virus Infections - epidemiology | Respiratory Syncytial Viruses - physiology | Humans | Respiratory Syncytial Virus Infections - diagnosis | Respiratory Syncytial Virus, Human - classification | Animals | Respiratory Syncytial Virus Infections - etiology | Respiratory Syncytial Viruses - classification | Respiratory Syncytial Virus, Human - physiology | Respiratory Syncytial Virus Infections - prevention & control | Mice | Respiratory Syncytial Virus Infections - therapy | Virus diseases | Infection | Antiviral agents | Fibrin | Analysis | Diagnosis | Vaccines | Index Medicus
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2016, Volume 138, Issue 3, pp. 814 - 824.e11
Allergy and Immunology | Group 2 innate lymphoid cells | thymic stromal lymphopoietin | IL-13 | type 2 immunity (TH2) | IL-33 | respiratory syncytial virus | type 2 immunity (T | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Interleukin-13 - immunology | Interleukin-33 - immunology | Respiratory Syncytial Virus Infections - immunology | Viral Load | Mice, Knockout | Lung - virology | Animals | Lymphocytes - immunology | Female | Mucus - metabolism | Lung - metabolism | Mice, Inbred BALB C | Respiratory Syncytial Virus Infections - virology | Cytokines - genetics | Lung - immunology | Cytokines - immunology | Virus diseases | Medical colleges | Infants | Health aspects | Mortality | Analysis | Asthma | Proteins | Ostomy | Disease | Lungs | Cytokines | Viruses | Infections | Index Medicus | Abridged Index Medicus | Immune Deficiencies, Infection, and Systemic Immune Disorders | MFI, Mean fluorescence intensity | BAL, Bronchoalveolar lavage | WT, Wild-type | TSLP, Thymic stromal lymphopoietin | KO, Knockout | INSPIRE, Infant Susceptibility to Pulmonary Infections and Asthma Following RSV Exposure | PAS, Periodic acid–Schiff | ILC2, Group 2 innate lymphoid cell | TSLPR, Thymic stromal lymphopoietin receptor | ILC, Innate lymphoid cell | RSV, Respiratory syncytial virus | PFU, Plaque-forming units
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 35, Issue 5, pp. 757 - 766
Allergy and Immunology | Human respiratory syncytial virus | Pulmonary inflammation | Bacillus Calmette et Guerin | T cells | Th1 | Viral infection | Th17 | Recombinant vaccine | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Immunogenicity, Vaccine | Respiratory Syncytial Virus Vaccines - immunology | Humans | Nucleoproteins - genetics | Interleukin-17 - immunology | Viral Proteins - immunology | Th1 Cells - immunology | Respiratory Syncytial Virus Infections - immunology | Th17 Cells - virology | Th1 Cells - virology | BCG Vaccine - genetics | Lung - virology | Th17 Cells - drug effects | Immunity, Cellular - drug effects | Respiratory Syncytial Virus Infections - prevention & control | Immunization Schedule | Respiratory Syncytial Virus Infections - virology | Respiratory Syncytial Virus, Human - pathogenicity | Nucleoproteins - immunology | Th1 Cells - drug effects | Respiratory Syncytial Virus, Human - drug effects | Viral Proteins - genetics | Interleukin-17 - biosynthesis | Animals | CD8-Positive T-Lymphocytes - virology | Lymphocyte Activation - drug effects | Respiratory Syncytial Virus, Human - immunology | CD8-Positive T-Lymphocytes - drug effects | Interferon-gamma - immunology | Lung - drug effects | Respiratory Syncytial Virus Vaccines - administration & dosage | BCG Vaccine - immunology | Th17 Cells - immunology | Vaccines, Synthetic | Mice | Mice, Inbred BALB C | CD8-Positive T-Lymphocytes - immunology | Respiratory Syncytial Virus Vaccines - genetics | BCG Vaccine - administration & dosage | Interferon-gamma - biosynthesis | Lung - immunology | Virus diseases | Prevention | Vaccines | Health aspects | Antigens | Pneumonia | Vaccination | Bacterial pneumonia | Disease susceptibility | Epidemics | Pathogenesis | Neutrophils | Viruses | T cell receptors | Infections | Pathology | Respiratory syncytial virus | Lungs | Lymphocytes | Laboratory animals | Public health | Index Medicus | Life Sciences | Human health and pathology
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 12/2017, Volume 216, Issue 11, pp. 1362 - 1370
Clinical trial | Adjuvant | Vaccine | Respiratory syncytial virus | Subunit | Efcacy | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Viral Fusion Proteins - administration & dosage | Glucosides - pharmacology | Respiratory Syncytial Virus Vaccines - immunology | Adjuvants, Immunologic - administration & dosage | Adjuvants, Pharmaceutic | Double-Blind Method | Immunoglobulin G - blood | Humans | Middle Aged | Male | Antigens, Bacterial | Antibodies, Viral - blood | Respiratory Syncytial Virus Infections - immunology | Viral Fusion Proteins - immunology | Antigens, Viral - immunology | Influenza Vaccines - immunology | Respiratory Syncytial Virus, Human - immunology | Lipid A - pharmacology | Respiratory Syncytial Virus Infections - prevention & control | Antibody Formation | Female | Aged | Respiratory Syncytial Virus Vaccines - therapeutic use | Antibodies, Neutralizing - blood | Virus diseases | Prevention | Usage | Viral vaccines | Patient outcomes | Clinical trials | Respiratory tract diseases | Dosage and administration | Research | Index Medicus | Abridged Index Medicus | clinical trial | Major and Brief Reports | vaccine | subunit | respiratory syncytial virus | efficacy
Journal Article